Third Surgery Department, The Fourth Hospital of Hebei Medical University, No.12, Jian-Kang Road, Shijiazhuang, 050019, Hebei, China.
AMITA Health Saint Joseph Hospital Chicago, 2900 N. Lake Shore Drive, Chicago, IL, 60657, USA.
J Robot Surg. 2023 Jun;17(3):1151-1158. doi: 10.1007/s11701-023-01528-8. Epub 2023 Jan 11.
The application of Enhanced Recovery After Surgery (ERAS) protocol in gastrointestinal surgery has been widely accepted. The aim of this study was to compare the effect of ERAS in total robotic distal gastrectomy (TRDG) versus 3D total laparoscopic distal gastrectomy (3D-TLDG) for gastric cancer.
We retrospectively evaluated 73 patients underwent TRDG and 163 patients who received 3D-TLDG. The propensity score was used for matching analysis according to a 1:1 ratio, so that there was no significant difference in the baseline data between the two groups. The short-term effect and safety of the two groups were compared.
The TRDG group had a less intraoperative bleeding (30.21 ± 13.78 vs. 41.44 ± 17.41 ml, P < 0.001), longer intraoperative preparation time (31.05 ± 4.93 vs. 15.48 ± 2.43 min, P < 0.001), shorter digestive tract reconstruction time (32.67 ± 4.41 vs. 39.78 ± 4.95 min, P < 0.001), shorter postoperative ambulation time (14.07 ± 8.97 vs. 17.49 ± 5.98 h, P = 0.007), shorter postoperative anal exhaust time (1.78 ± 0.79 vs. 2.18 ± 0.79 days, P = 0.003), shorter postoperative hospital stay (7.74 ± 3.15 vs. 9.97 ± 3.23 days, P < 0.001), lower postoperative pain score (P = 0.006) and higher hospitalization cost (89,907.15 ± 17,147.19 vs. 125,615.82 ± 11,900.80 RMB, P < 0.001) than the 3D-TLDG group.
TRDG and 3D-TLDG under ERAS protocol are safe and feasible. Compared with 3D-TLDG, the TRDG has better intraoperative bleeding control effect and greater advantages in digestive tract reconstruction. After the combination of ERAS protocol, TRDG also has certain advantages in the recovery process of patients after surgery.
加速康复外科(ERAS)方案在胃肠外科中的应用已被广泛接受。本研究旨在比较 ERAS 方案在全机器人辅助远端胃癌根治术(TRDG)与 3D 全腹腔镜远端胃癌根治术(3D-TLDG)中的效果。
我们回顾性评估了 73 例行 TRDG 的患者和 163 例行 3D-TLDG 的患者。根据 1:1 比例使用倾向评分匹配分析,使两组的基线数据无显著差异。比较两组的短期疗效和安全性。
TRDG 组术中出血量更少(30.21±13.78 比 41.44±17.41 ml,P<0.001),术中准备时间更长(31.05±4.93 比 15.48±2.43 min,P<0.001),消化道重建时间更短(32.67±4.41 比 39.78±4.95 min,P<0.001),术后下床活动时间更早(14.07±8.97 比 17.49±5.98 h,P=0.007),术后肛门排气时间更早(1.78±0.79 比 2.18±0.79 天,P=0.003),术后住院时间更短(7.74±3.15 比 9.97±3.23 天,P<0.001),术后疼痛评分更低(P=0.006),住院费用更高(89907.15±17147.19 比 125615.82±11900.80 人民币,P<0.001)。
ERAS 方案下的 TRDG 和 3D-TLDG 均安全可行。与 3D-TLDG 相比,TRDG 在术中出血控制方面具有更好的效果,在消化道重建方面具有更大的优势。在 ERAS 方案的结合下,TRDG 在患者术后恢复过程中也具有一定的优势。